首页> 美国卫生研究院文献>The Korean Journal of Physiology Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology >Diclofenac a Non-steroidal Anti-inflammatory Drug Inhibits L-type Ca2+ Channels in Neonatal Rat Ventricular Cardiomyocytes
【2h】

Diclofenac a Non-steroidal Anti-inflammatory Drug Inhibits L-type Ca2+ Channels in Neonatal Rat Ventricular Cardiomyocytes

机译:非甾体抗炎药双氯芬酸抑制新生大鼠心室心肌细胞的L型Ca2 +通道。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A non-steroidal anti-inflammatory drug (NSAID) has many adverse effects including cardiovascular (CV) risk. Diclofenac among the nonselective NSAIDs has the highest CV risk such as congestive heart failure, which resulted commonly from the impaired cardiac pumping due to a disrupted excitation-contraction (E-C) coupling. We investigated the effects of diclofenac on the L-type calcium channels which are essential to the E-C coupling at the level of single ventricular myocytes isolated from neonatal rat heart, using the whole-cell voltage-clamp technique. Only diclofenac of three NSAIDs, including naproxen and ibuprofen, significantly reduced inward whole cell currents. At concentrations higher than 3 µM, diclofenac inhibited reversibly the Na+ current and did irreversibly the L-type Ca2+ channels-mediated inward current (IC50=12.89±0.43 µM) in a dose-dependent manner. However, nifedipine, a well-known L-type channel blocker, effectively inhibited the L-type Ca2+ currents but not the Na+ current. Our finding may explain that diclofenac causes the CV risk by the inhibition of L-type Ca2+ channel, leading to the impairment of E-C coupling in cardiac myocytes.
机译:非甾体抗炎药(NSAID)具有许多不良反应,包括心血管(CV)风险。非选择性非甾体抗炎药中的双氯芬酸具有最高的CV风险,例如充血性心力衰竭,这通常是由于激发收缩(E-C)耦合中断而导致心脏泵浦受损所致。我们使用全细胞电压钳技术研究了双氯芬酸对L型钙通道的作用,该通道对从新生大鼠心脏分离的单个心室肌细胞水平的E-C偶联至关重要。包括萘普生和布洛芬在内的三种NSAID的双氯芬酸只能显着降低内向全细胞电流。在高于3 µM的浓度下,双氯芬酸可逆地抑制Na + 电流,并且不可逆地抑制L型Ca 2 + 通道介导的内向电流(IC50 = 12.89±0.43 µM )的剂量依赖性。但是,硝苯地平是一种著名的L型通道阻滞剂,可以有效抑制L型Ca 2 + 电流,但不能抑制Na + 电流。我们的发现可能解释双氯芬酸通过抑制L型Ca 2 + 通道而引起CV风险,从而导致心肌细胞E-C偶联受损。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号